These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25505026)

  • 21. Successful cholecystectomy in a patient with aplastic anemia-paroxysmal nocturnal hemoglobinuria during eculizumab treatment.
    Ando K; Gotoh A; Yoshizawa S; Gotoh M; Iwabuchi T; Ito Y; Ohyashiki K
    Ann Hematol; 2012 Dec; 91(12):1987-8. PubMed ID: 22739575
    [No Abstract]   [Full Text] [Related]  

  • 22. Eculizumab in paroxysmal nocturnal hemoglobinuria.
    Pride YB
    N Engl J Med; 2006 Dec; 355(26):2787; author reply 2787-8. PubMed ID: 17195305
    [No Abstract]   [Full Text] [Related]  

  • 23. [Evidence of the efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria].
    Nau JY
    Rev Med Suisse; 2006 Oct; 2(81):2255. PubMed ID: 17076159
    [No Abstract]   [Full Text] [Related]  

  • 24. AOHE: manuscript AOHE-D-16-00564 paroxysmal nocturnal hemoglobinuria with autoimmune hemolytic anemia following eculizumab therapy-with large granular lymphocytic leukemia.
    Visweshwar N; Jaglal M; Booth C; Griffin P; Laber D
    Ann Hematol; 2016 Oct; 95(10):1747-9. PubMed ID: 27449072
    [No Abstract]   [Full Text] [Related]  

  • 25. Eculizumab in paroxysmal nocturnal hemoglobinuria.
    Takita M; Matsumura T; Kami M
    N Engl J Med; 2006 Dec; 355(26):2787; author reply 2787-8. PubMed ID: 17193722
    [No Abstract]   [Full Text] [Related]  

  • 26. Current and future pharmacologic complement inhibitors.
    Risitano AM
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):561-82. PubMed ID: 26043392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful use of eculizumab in a pediatric patient treated for paroxysmal nocturnal hemoglobinuria.
    Bauters T; Bordon V; Robays H; Benoit Y; Dhooge C
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):e346-8. PubMed ID: 22767128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse reactions and medical approach to paroxysmal nocturnal hemoglobinuria.
    Colombo GM; Guglielmelli E; Sacco T; Cicchinelli M
    Minerva Med; 2007 Feb; 98(1):87-8. PubMed ID: 17372586
    [No Abstract]   [Full Text] [Related]  

  • 29. Severe Infection of Pseudomonas aeruginosa during Eculizumab Therapy for Paroxysmal Nocturnal Hemoglobinuria.
    Kawakami T; Nakazawa H; Kurasawa Y; Sakai H; Nishina S; Senoo N; Senoo Y; Ishida F
    Intern Med; 2018 Jan; 57(1):127-130. PubMed ID: 29021487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria.
    Hill A
    Clin Adv Hematol Oncol; 2008 Jul; 6(7):499-500. PubMed ID: 18654116
    [No Abstract]   [Full Text] [Related]  

  • 31. Eculizumab in paroxysmal nocturnal hemoglobinuria.
    Singh J; Malani AK; Pabla M
    N Engl J Med; 2006 Dec; 355(26):2786; author reply 2787-8. PubMed ID: 17195307
    [No Abstract]   [Full Text] [Related]  

  • 32. [With paroxysmal nocturnal haemoglobinuria and treatment with eculizumab].
    Algado JT; Luque R; Nuñez R; Sanchez B
    Enferm Infecc Microbiol Clin; 2012 Feb; 30(2):109-10. PubMed ID: 22197277
    [No Abstract]   [Full Text] [Related]  

  • 33. Drugs that inhibit complement.
    Schrezenmeier H; Höchsmann B
    Transfus Apher Sci; 2012 Feb; 46(1):87-92. PubMed ID: 22169380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management of pregnancy and delivery in patients with paroxysmal nocturnal hemoglobinuria].
    Usuki K
    Rinsho Ketsueki; 2015 Jul; 56(7):785-94. PubMed ID: 26251141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eculizumab in paroxysmal nocturnal hemoglobinuria.
    Kathula SK
    N Engl J Med; 2006 Dec; 355(26):2786; author reply 2787-8. PubMed ID: 17192547
    [No Abstract]   [Full Text] [Related]  

  • 36. Failure of eculizumab to correct paroxysmal cold hemoglobinuria.
    Gregory GP; Opat S; Quach H; Shortt J; Tran H
    Ann Hematol; 2011 Aug; 90(8):989-90. PubMed ID: 21110191
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of pregnancy in paroxysmal nocturnal hemoglobinuria on long-term eculizumab.
    Vekemans MC; Lambert C; Ferrant A; Saussoy P; Havelange V; Debiève F; Van Den Neste E; Michaux L
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):464-6. PubMed ID: 25688464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemolytic anemia after eculizumab in paroxysmal nocturnal hemoglobinuria.
    Berzuini A; Montanelli F; Prati D
    N Engl J Med; 2010 Sep; 363(10):993-4. PubMed ID: 20818912
    [No Abstract]   [Full Text] [Related]  

  • 39. Limits on use of health economic assessments for rare diseases.
    Hyry HI; Stern AD; Cox TM; Roos JC
    QJM; 2014 Mar; 107(3):241-5. PubMed ID: 24453281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paroxysmal nocturnal hemoglobinuria (PNH) and pregnancy in the era of eculizumab.
    Danilov AV; Smith H; Craigo S; Feeney DM; Relias V; Miller KB
    Leuk Res; 2009 Jun; 33(6):e4-5. PubMed ID: 18952283
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.